Outcomes in highly sensitized pediatric heart transplant patients using current management strategies  Alfred Asante-Korang, MD, Ernest K. Amankwah, PhD,

Slides:



Advertisements
Similar presentations
Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.
Advertisements

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I
Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation  Stijn E. Verleden, PhD, David Ruttens, MD, Elly Vandermeulen,
Evan P. Kransdorf, MD, PhD, Michelle M. Kittleson, MD, PhD, Jignesh K
Management of Anticoagulation in Patients with Mechanical Circulatory Support Using a Physician-Based Versus a Pharmacist Directed Anticoagulation Clinic-Based.
Patterns and Predictors of Physical Functional Disability at 5 to 10 Years After Heart Transplantation  Kathleen L. Grady, PhD, RN, David C. Naftel, PhD,
The Journal of Heart and Lung Transplantation
T. Oyaizu, S.-Y. Fung, A. Shiozaki, B. Han, S. Keshavjee, M. Liu 
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.
Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,
Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.
Low vitamin D levels are associated with increased rejection and infections after lung transplantation  Erin M. Lowery, MD, Bradford Bemiss, MD, Thomas.
The Journal of Heart and Lung Transplantation
Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 
Two decades of pediatric lung transplant in the United States: Have we improved?  Farhan Zafar, MD, Jeffrey S. Heinle, MD, Marc G. Schecter, MD, Joseph.
Oral tacrolimus for pediatric steroid-resistant ulcerative colitis
Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab  Tomoko Funazo,
Jeffrey H. Barsuk, MD, MS, Elaine R
Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis  C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures  J. Saravana Ganesh, FRCS, Chris.
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis  Akin Cam, MD, Sachin S. Goel, MD, Shikhar Agarwal, MD, MPH,
Early readmission for congestive heart failure predicts late mortality after cardiac surgery  Richard Lee, MD, MBA, Natalie Homer, BS, Adin-Cristian Andrei,
The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non–Small-Cell.
Jeffrey Phillip Jacobs, MD, Alfred Asante-Korang, MD, Sean M
Comparative Effectiveness Research
Less Is More in Post Pediatric Heart Transplant Care
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS 
A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales 
David L. S. Morales, MD, William J. Dreyer, MD, Susan W
Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab  Tomoko Funazo,
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Relevance of Platinum-Sensitivity Status in Relapsed/Refractory Extensive-Stage Small- Cell Lung Cancer in the Modern Era: A Patient-Level Analysis of.
Quality of life outcomes are equivalent after lobectomy in the elderly
Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel  M. Weinberger, S. Yaron, V. Agmon, R. Yishai, A.
Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy  Todd.
Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature  Caicun Zhou, MD, PhD, Luan Di Yao, MD 
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E
Volume 133, Issue 2, Pages (August 2007)
A first start for lung transplantation?
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients  Valerie Waters, Eshetu G. Atenafu, Annie.
Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease  Hao-Xian Yang,
Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer  Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients  Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.
Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases  Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,
Jeffrey H. Barsuk, MD, MS, Elaine R
Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: An analysis of the United Network for.
Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer  Eun Young Kim, MD, Young Saing Kim, MD, Inkeun Park, MD,
Volume 83, Issue 3, Pages (March 2013)
Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD 
Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival  John P. Griffin, MD, Charles E.
Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients  Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,
The Journal of Thoracic and Cardiovascular Surgery
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer  Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,
Should heart transplantation be considered as a treatment option for patients aged 70 years and older?  Jeffrey A Morgan, MD, Ranjit John, MD, Donna M.
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
Contemporary outcomes of complete atrioventricular septal defect repair: Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database 
Presentation transcript:

Outcomes in highly sensitized pediatric heart transplant patients using current management strategies  Alfred Asante-Korang, MD, Ernest K. Amankwah, PhD, Mayra Lopez-Cepero, PhD, Jeremy Ringewald, MD, Jennifer Carapellucci, BSN, Diane Krasnopero, DNP, Alex Berg, ARNP, James Quintessenza, MD, Jeffrey P. Jacobs, MD  The Journal of Heart and Lung Transplantation  Volume 34, Issue 2, Pages 175-181 (February 2015) DOI: 10.1016/j.healun.2014.09.027 Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 1 Individual reductions in percent PRA before and after desensitization (p < 0.0001). The Journal of Heart and Lung Transplantation 2015 34, 175-181DOI: (10.1016/j.healun.2014.09.027) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 2 Kaplan–Meier survival plot comparing sensitized patients with non-sensitized patients after 2005. Log-rank test shows no statistically significant difference between the two curves (p < 0.28). The Journal of Heart and Lung Transplantation 2015 34, 175-181DOI: (10.1016/j.healun.2014.09.027) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 3 Kaplan–Meier survival plot comparing sensitized patients with non-sensitized patients before 2005. Log-rank test shows a statistically significant difference between the two curves (p < 0.046). The Journal of Heart and Lung Transplantation 2015 34, 175-181DOI: (10.1016/j.healun.2014.09.027) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions